Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-08-08
1998-05-19
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 4242061, A61K 3800, A61K 3855
Patent
active
057536244
ABSTRACT:
Methods and compositions are provided for alleviation of disease states involving plaque formation, such as are manifested in Alzheimer's Disease and other amyloid disorders, and arteriosclerotic disease. Methods for the treatment of herpes virus infections by administration of thimerosal are further provided by the invention.
REFERENCES:
patent: 4294818 (1981-10-01), McMichael et al.
patent: 4521405 (1985-06-01), McMichael et al.
patent: 4666829 (1987-05-01), Colenneo et al.
patent: 4704273 (1987-11-01), McMichael
patent: 4705685 (1987-11-01), McMichael
patent: 4816416 (1989-03-01), Auerbach
patent: 4880626 (1989-11-01), McMichael
patent: 4912206 (1990-03-01), Goldgaber et al.
patent: 5187153 (1993-02-01), Cordell et al.
patent: 5223482 (1993-06-01), Schilling et al.
Bahmanyar et al., "Characterization of Antineurofilament Autoantibodies in Creutzfeldt-jakob Disease," J. Neuropathol. Exp. Neurol., 43(4):369-375 (Jul. 1984).
Bahmanyar et al., "Serum Antibodies to Neurofilament Antigens in Patients with Neurological and Other diseases and in Healthy cControls," J. Neuroimmunol. , 5:191-196 (1983).
Baudry et al., "Low Levels of Calpain Activity in Chiropera Brain: Implications for Mechanisms of Aging," Neurobiol. Aging, 7:255-258 (1986).
Bruce, "Amyloid Plaques in Experimental Scrapie: Factors Influencing the Occurance of Cerebral Amyloid in Inbred Mice," J. Neuropathol. Exp. Neurol., 37:595 (1978).
Bruist et al., "Synthesis of a Site-Specific DNA-Binding Peptide," Science, 235:777-780 (Feb. 13, 1987).
Castano et al., "In Vitro Formulation of Amyloid Fibrils from Two Synthetic Peptides of Different Lengths Homologous to Alzheimer's Disease .beta.-Protein," Biochem. Biophys. Res. Com., 141(2):782-789 (Dec. 15, 1986).
Cohen and Calkins, "Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins," Nature, 183:1202-1203 (Apr. 25, 1959).
Cohen and Calkins, "The Isolation of Amyloid Fibrils and a Study of the Effect of Collagenase and Hyaluronidase," J. Cell Biol., 183:481-486 (1964).
Cohen et al., "Analysis of Histology and Staining Reactions of Casein-Induced Amyloidosis in the Rabbit," Am. J. Pathol., 35(5):971-989 (Sep.-Oct. 1959).
Dahl and Bignami, "Immunochemical Cross-Reactivity of Normal Neurofibrils and Aluminum-Induced Neurofibrillary Tangles," Exp. Neurol., 58:74-80 (1978).
Elizan et al., "Antineurofilament Antibodies in Postencephalitic and Idiopathic Parkinson's Disease," J. Neurol. Sci., 59:341-347 (1983).
Gajdusek, "Hypothesis: Interference with Axonal Transport of Neurofilament as a Common Pathogenetic Mechanism in Certain Diseases of the Central Nervous System," New Eng. J. Med., 312(11):714-719 (Mar. 14, 1985).
Ghiso et al., "Alzheimer's Disease Amyloid Precursor Protein is Present in Senile Plaques and Cerebrospinal Fluid: Immunohistochemical and Biochemical Characterization," Biochem. Biophys. Res. Com., 163(1):430-437 (Aug. 30, 1989).
Glenner, "Alzheimer's Disease The Commonest Form of Amyloidosis," Arch. Pathol. Lab. Med., 107:281-282 (Jun. 1983).
Glenner and Wong, "Alzheimer's Disease and Down's Syndrome: Sharing of a Unique Cerebrovascular Amyloid Fibril Protein," Biochem. Biophys. Res. Com., 122(3):1131-1135 (1984).
Goldman et al., "Cytoplasmic Fibers in Mammalian Cells: Cytoskeletal and Contractile Elements," Ann. Rev. Physiol., 41:703-722 (1979).
Griffin et al., "Slow Axonal Transport of Neurofilament Proteins: Impairment by .beta.,.beta.'-Iminodipropionitrile Administration," Science, 202:633-635 (Nov. 1978).
Hoffman and Lasek, "The Slow Component of Axonal Transport," J. Cell. Biol., 66:351-366 (1975).
Howard and Pilkington, "Antibodies to fibronectin bind plaques and other structures in Alzheimer's disease and control brain," Neuroscience Letters, 118:71-76 (1990).
Iqbal et al., "Chemical Relationship of the Paired Helical Filaments of Alzheimer's Dementia to Normal Human Neurofilaments and Neurotubules," Brain Res., 142:321-332 (1978).
Itagaki, et al., "Presence of T-Cytotoxic Suppressor and Leucocyte Common Antigen Positive Cells in Alzheimer's Disease Brain Tissue," Neuroscience Letters, 91:259-264 (1988).
Joachim and Selkoe, "Amyloid Protein in Alzheimer's Disease," J. Gerontology, 44:(4):B77-84 (1989).
Jones et al., "Evidence for Active Epstein-Barr Virus Infection in Patients with Persistent, Unexplained Illnesses: Elevated Anti-Early Antigen Antibodies," Annals of Internal Medicine, 102:1-6 (Jan. 1985).
Kang et al., "The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor," Nature, 325:733-736 (Feb. 19, 1987).
Kilbourne, "Inactivated Influenza Virus Vaccines" in Vaccines, pp. 420-434, Plotkin et al., Eds., W.B. Saunders Company, Philadelphia (1988).
Knight, "Dopamine-Receptors-Stimulating Autoantibodies: A Possible Cause of Schizophrenia," Lancet, 82:1073-1076 (Nov. 13, 1982). (May 30, 1987).
Lasak, "The Dynamic Ordering of Neuronal Cytoskeletons," Neurosciences. Res. Prog. Bull., 19(1):7-32 (1981).
Lieberman, "The Role of the Rubella Virus In the Chronic Fatigue Syndrome," Clinical Ecology, 7(3):51-54 (1990).
Marx, "A New Link in the Brain's Defenses," Science, 256:1278-1280 (May 29, 1992).
Marx, "Testing of Autoimmune Therapy Begins," Science, 252:27-28 (Apr. 5, 1991).
Masters et al., "Amyloid plaque core protein in Alzheimer disease and Down syndrome," Proc. Natl. Acad. Sci. USA, 82:4245-4249 (Jun. 1985).
Melnick et al., "Possible Role of Cytomegalovirus in Atherogenesis," JAMA, 263(16):2204-207 (Apr. 25, 1990).
Miller, "A Double-Blind Study of Food Extract Injection Therapy: A Preliminary Report," Annals of Allergy, 38:185-191 (Mar. 1977).
Miller, "Influenza: Rapid Relief Without Drugs," Clinical Medicine, 81:16-19 (Sep. 1974).
Moos and Solomon, "Psychologic Comparisons Between Women with Rheumatoid Arthritis and their Nonarthritic Sisters," Psychosom. Med., 27(2):135-149 (1965).
Newcombe and Cohen, "Solubility Characteristics of Isolated Amyloid Fibrils," Biochem. et Biophys. Acta, 104:480-486 (1965).
Rabins and Folstein, "The Dementia Patient: Evaluation and Care," Geriatrics, 38(8):99-117 (Aug. 1983).
Reines, "Early Clinical Trials in Alzheimer's Disease: Selection and Evaluation of Drug Canidates," Progress in Clin. Biol. Res., 1283-1290 (1989).
Samet, Peptides Offer Promise forTtreating Alzheimer's and other Neurodiseases, Genetic Engineering News, p. 24 (Jul./Aug. 1991).
Selkoe et al., "Isolation of Low-Molecular-Weight Proteins from Amyloid Plaque Fibers in Alzheimer's disease," J. Neurochem., 46:1820-1834 (1986).
Shacks et al., "Increased Serum IgG4 Levels in Acute Epstein-Barr Viral Mononucleosis," Annals of Allergy, 54:284-288 (Apr. 1985).
Shelanski and Liem, "Neurofilaments," J. Neurochem., 33:5-13 (1979).
Snow and Wight, "Proteoglycans in the Pathogenesis of Alzheimer's Disease and Other Amyloidoses," Neurobio. Aging, 10:481-497 (1989).
Solomon, "Psychoneuroimmunology: Interactions Between Central Nervous System and Immune System," J. Neurosci. Res., 18:1-9 (1987).
Solomon and Moos, "Emotions, Immunity, and Disease," Arch. Gen. Psychiatry, 11:657-674 (Dec. 1964).
Strauss et al., "Persistng Illness and Fatigue in Adults with Evidence of Epstein-Barr Virus Infection," Annals of Internal Medicine, 102:7-16 (1985).
Tanzi et al., "Amyloid .beta. Protein Gene: cDNA, mRNA Distribution and Genetic Linkage Near the Alzheimer Locus," Science, 235:880-884 (Feb. 20, '1987).
Tingle et al., "Prospective Immunological Assessment of Arthritis Induced by Rubella Vaccine," Infect. Immun., 40(1):22-28 (Apr. 1983).
Turnell et al., "Secondary Structure Prediction of Human SAA.sub.1 Presumptive Identification of Calcium and Lipid Binding Sites," Mol. Biol. Med., 3:387-407 (1986).
Turnell et al., "X-Ray Scattering and Diffraction by Wet Gels of AA Amyloid Fibrils," Mol. Biol. Med., 3:409-424 (1986).
Wirak et al., "Deposits of Amyloid .beta. Protein in the Central Nervous System Transgenic Mice," Science, 253:323-325 (Jul. 19, 1991).
Wong et al., "Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related," Proc. Natl. Acad. Sci. USA, 82:8729-8732 (Dec. 1985).
Kline Ellis L.
McMichael John
Milkhaus Laboratory, Inc.
Touzeau P. Lynn
Tsang Cecilia J.
LandOfFree
Materials and methods for treatment of plaquing disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods for treatment of plaquing disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for treatment of plaquing disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853040